GLAUCOMA THERAPEUTICS MARKET ANALYSIS

Regional Analysis

Glaucoma Therapeutics Market - Regional Analysis

On the basis of region, glaucoma therapeutics market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America holds dominant position in glaucoma therapeutics market, followed by Asia Pacific. Increasing prevalence of diabetes, increasing ocular disorders, and increasing number of blind and visually impaired people in turn opting for glaucoma treatment are expected to drive growth of the glaucoma therapeutic market in these region. For instance, According to National Federation of the Blind, 2014, an estimated 10 million people in the U.S. are blind or visually impaired. It is estimated that around 1.3 million people are legally blind in the U.S. and the number is projected to increase to 75,000 people annually in the U.S.

Asia Pacific is expected to gain a significant traction over the forecast period, owing to the government initiatives and awareness programs to eliminate the blindness, which in turn is propelling demand for glaucoma therapies in this region. For instance, in 2014, HelpAge India—a nonprofit organization—launched a special campaign to address the issue of blindness for underprivileged elderly populations of India.

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa